Facilitation of left ventricular function recovery post percutaneous coronary intervention by levosimendan.

[1]  C. O'connor,et al.  Coronary-artery bypass surgery in patients with left ventricular dysfunction. , 2011, The New England journal of medicine.

[2]  G. Lamas,et al.  Quality of life after late invasive therapy for occluded arteries. , 2009, The New England journal of medicine.

[3]  G. Alunni,et al.  Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. , 2009, European heart journal.

[4]  A. Cohen-Solal,et al.  Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. , 2007, JAMA.

[5]  M. Lauer,et al.  Myocardial Viability Testing and the Effect of Early Intervention in Patients With Advanced Left Ventricular Systolic Dysfunction , 2006, Circulation.

[6]  B. Gersh,et al.  Revascularization in severe left ventricular dysfunction: the role of viability testing. , 2005, Journal of the American College of Cardiology.

[7]  G. Filippatos,et al.  Effects of levosimendan on markers of left ventricular diastolic function and neurohormonal activation in patients with advanced heart failure. , 2005, The American journal of cardiology.

[8]  Jerome Sacks,et al.  Outcome of percutaneous coronary intervention versus coronary bypass grafting for patients with low left ventricular ejection fractions, unstable angina pectoris, and risk factors for adverse outcomes with bypass (the AWESOME Randomized Trial and Registry). , 2004, The American journal of cardiology.

[9]  L. Lehtonen,et al.  The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angioplasty in acute myocardial ischemia. , 2004, Journal of the American College of Cardiology.

[10]  Jeroen J. Bax,et al.  Early Versus Delayed Revascularization in Patients With Ischemic Cardiomyopathy and Substantial Viability: Impact on Outcome , 2003, Circulation.

[11]  James E. Davis,et al.  Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention. , 2002, The Annals of thoracic surgery.

[12]  J. Cleland,et al.  Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial , 2002, The Lancet.

[13]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[14]  J. Townend,et al.  Effects of coronary revascularisation on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium , 2001, Heart.

[15]  P. Pagel,et al.  Levosimendan, a New Positive Inotropic Drug, Decreases Myocardial Infarct Size via Activation of KATP Channels , 2000, Anesthesia and analgesia.

[16]  J. Mattera,et al.  Failure to improve left ventricular function after coronary revascularization for ischemic cardiomyopathy is not associated with worse outcome. , 1999, Circulation.

[17]  P. Pagel,et al.  Intracoronary Levosimendan Enhances Contractile Function of Stunned Myocardium , 1997, Anesthesia and analgesia.

[18]  J. O’Keefe,et al.  Angioplasty versus bypass surgery for multivessel coronary artery disease with left ventricular ejection fraction < or = 40%. , 1993, The American journal of cardiology.

[19]  F. Harrell,et al.  Surgical survival benefits for coronary disease patients with left ventricular dysfunction. , 1988, Circulation.

[20]  C. Maynard,et al.  Results of coronary artery surgery in patients with poor left ventricular function (CASS). , 1983, Circulation.

[21]  O. Yildiz.  Vasodilating mechanisms of levosimendan: involvement of K+ channels. , 2007, Journal of pharmacological sciences.

[22]  M. Tendera,et al.  Comparison of effectiveness of coronary artery bypass grafting versus percutaneous coronary intervention in patients with ischemic cardiomyopathy. , 2007, The American journal of cardiology.